Mycobacterium tuberculosis beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia

Journal of Infectious Diseases

Volumn 201, Issue 4, 2010, Pages 553-557

  Parwati, Ida ^a,b   Alisjahbana, Bachti ^a,b   Apriani, Lika ^a,b   Soetikno, Rista D ^a   Ottenhoff, Tom H ^c   Van Der Zanden, Adri G M ^d   Van Meer, Jos Der ^e   Van Soolingen, Dick ^f   VanCrevel, Reinout ^e  

^a Department of Clinical Pathology ^*  (Indonesia)

^b PADJADJARAN UNIVERSITY   (Indonesia)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Laboratory for Medical Microbiology and Public Health   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL STRAIN; CHINA; CONTROL GROUP; CONTROLLED STUDY; DRUG TREATMENT FAILURE; FEMALE; GENOTYPE; HUMAN; INDONESIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SPUTUM CULTURE; THORAX RADIOGRAPHY; TREATMENT DURATION;

ADULT; ANTITUBERCULAR AGENTS; FEMALE; GENOTYPE; HUMANS; INDONESIA; MALE; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE; TUBERCULOSIS;

EID: 75749108519     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/650311     Document Type: Article

References (15)

1. European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis. Beijing/ W genotype Mycobacterium tuberculosis and drug resistance. Emerg Infect Dis 2006; 12(5):736-743.
2. Wirth T, Hildebrand F, Allix-Beguec C, et al. Origin, spread and demography of the Mycobacterium tuberculosis complex. PLoS Pathog 2008;4(9):e1000160.
3. Drobniewski F, Balabanova Y, Nikolayevsky V, et al. Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA 2005;293(22):2726-2731.
4. Lan NT, Lien HT, Tung LB, Borgdorff MW, Kremer K, van Soolingen D. Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam. Emerg Infect Dis 2003; 9(12): 1633-1635.
5. Parwati I, van Crevel R, Sudiro M, et al. Mycobacterium tuberculosis population structures differ significantly on two Indonesian Islands. J Clin Microbiol 2008;46(11):3639-3645.
6. Alisjahbana B, Sahiratmadja E, Nelwan EJ, et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 2007;45(4):428-435.
7. Ruslami R, van Crevel R, van de Berge E, Alisjahbana B, Aarnoutse RE. A step-wise approach to find a valid and feasible method to detect non-adherence to tuberculosis drugs. Southeast Asian J Trop Med Public Health 2008;39(6):1083-1087.
8. van Klingeren B, Dessens-Kroon M, van der Laan T, Kremer K, van Soolingen D. Drug susceptibility testing of Mycobacterium tuberculosis complex by use of a high-throughput, reproducible, absolute concentration method. J Clin Microbiol 2007; 45(8) :2662-2668.
9. Telenti A, Honore N, Bernasconi C, et al. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol 1997; 35(3):719-723.
10. van Crevel R, Nelwan RH, de Lenne W, et al. Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment. Emerg Infect Dis 2001;7(5):880-883.
11. Dormans J, Burger M, Aguilar D, et al. Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model. Clin Exp Immunol 2004; 137(3):460-468.
12. Sun YJ, Lim TK, Ong AK, Ho BC, Seah GT, Paton NI. Tuberculosis associated with Mycobacterium tuberculosis Beijing and non-Beijing genotypes: a clinical and immunological comparison. BMC Infect Dis 2006; 6:105.
13. Feng JY, Su WJ, Tsai CC, Chang SC. Clinical impact of Mycobacterium tuberculosis W-Beijing genotype strain infection on aged patients in Taiwan. J Clin Microbiol 2008;46(9):3127-3129.
14. Borgdorff MW, Van Deutekom H, De Haas PE, Kremer K, Van Soolingen D. Mycobacterium tuberculosis, Beijing genotype strains not associated with radiological presentation of pulmonary tuberculosis. Tuberculosis (Edinb) 2004; 84(5) :337-340.
15. Parwati I, van Crevel R, van Soolingen D. Successful emergence of the Mycobacterium tuberculosis Beijing genotype strains: review of possible underlying mechanisms. Lancet Infect Dis (in press).